Secondary Myelofibrosis Completed Phase Trials for Ganciclovir (DB01004)

IndicationStatusPhase
DBCOND0030964 (Secondary Myelofibrosis)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01199562Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant